Blood-based biomarkers can quantify the degree of tissue-related inflammation and mucosal damage in Inflammatory Bowel Disease (IBD) patients. In addition, we also explore how fistulizing and fibrostenotic endotypes can be identified.
CPa9-HNE is a biomarker of human neutrophil elastase degraded calprotectin (CPa9-HNE), a novel serum calprotectin that is a biomarker of true neutrophil activity, eliminating the need for fecal samples.
